Table of Contents Table of Contents
Previous Page  679 / 1173 Next Page
Information
Show Menu
Previous Page 679 / 1173 Next Page
Page Background

1/03/2016

18

Contextual lethality

High specificity

Low toxicity (different from RT)

Interaction with RT

Radiosensitivity

Hypoxia

Proliferation

Therapeutic index

Target driven

Synthetic lethality

Contextual lethality

Immune modulation

Hanahan & Weinberg Cell 2011

Tumor vasculature as a target

Angiogenesis inhibiting agents

Target angiogenesis process

E.g. bevacizumab